Functional effect of FGF2- and FGF8-expanded ventral mesencephalic precursor cells in a rat model of Parkinson's disease

Brain Research

Volumn 1218, Issue , 2008, Pages 13-20

  Jensen, Pia ^a   Pedersen, Emil G ^a   Zimmer, Jens ^a   Widmer, Hans R ^b   Meyer, Morten ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

6 hydroxydopamine; Behavior; Cell propagation; Dopamine; Progenitor cell; Transplantation

Indexed keywords

AMPHETAMINE; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 8; MITOGENIC AGENT; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; CORPUS STRIATUM; EMBRYO; IN VITRO STUDY; MESENCEPHALON; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; STEM CELL;

ADRENERGIC AGENTS; AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM STIMULANTS; DISEASE MODELS, ANIMAL; EMBRYO, MAMMALIAN; FEMALE; FETAL TISSUE TRANSPLANTATION; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 8; MESENCEPHALON; MOTOR ACTIVITY; NEOSTRIATUM; NEURONS; OXIDOPAMINE; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; STEM CELLS; TIME FACTORS; TYROSINE 3-MONOOXYGENASE;

RATTUS;

EID: 46349091450     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.04.039     Document Type: Article

References (28)

1. Andersen R.K., Johansen M., Blaabjerg M., Zimmer J., and Meyer M. Neural tissue-spheres: a microexplant culture model for propagation of precursor cells from the rat forebrain subventricular zone. J. Neurosci. Methods 165 (2007) 55-63
2. Arenas E. Stem cells in treatment of Parkinson's disease. Brain Res. Bull. 57 (2002) 795-808
3. Brundin P., Barbin G., Strecker R.E., Isacson O., Prochiantz A., and Bjorklund A. Survival and function of dissociated rat dopamine neurones grafted at different developmental stages or after being cultured in vitro. Brain Res. 467 (1988) 233-243
4. Brundin P., Karlsson J., Emgard M., Schierle G.S., Hansson O., Petersén Å., and Castilho R.F. Improving the survival of grafted dopaminergic neurons: a review over current approaches. Cell Transplant. 9 (2000) 179-195
5. Crossley P.H., Martinez S., and Martin G.R. Midbrain development induced by FGF8 in the chick embryo. Nature 380 (1996) 66-68
6. Daadi M.M., and Weiss S. Generation of tyrosine hydroxylase-producing neurons from precursors of the embryonic and adult forebrain. J. Neurosci. 19 (1999) 4484-4497
7. Gage F.H., Coates P.W., Palmer T.D., Kuhn H.G., Fisher L.J., Suhonen J.O., Peterson D.A., Suhr S.T., and Ray J. Survival and differentiation of adult neural progenitor cells transplanted to the adult brain. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 11879-11883
8. Gramsbergen J.B., Sandberg M., Moller Dall A., Kornblit B., and Zimmer J. Glutathione depletion in nigrostriatal slice cultures: GABA loss, dopamine resistance and protection by the tetrahydrobiopterin precursor sepiapterin. Brain Res. 935 (2002) 47-58
9. Jakobsen B., Gramsbergen J.B., Moller Dall A., Rosenblad C., and Zimmer J. Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP toxicity by GDNF. Eur. J. Neurosci. 21 (2005) 2939-2948
10. Jensen P., Bauer M., Jensen C.H., Widmer H.R., Gramsbergen J.B., Blaabjerg M., Zimmer J., and Meyer M. Expansion and characterization of ventral mesencephalic progenitor cells: Influence of mitogens and investigation of FA1 as a potential dopaminergic marker. J. Neurosci. Res. 85 (2007) 1884-1893
11. Kim J.Y., Koh H.C., Lee J.Y., Chang M.Y., Kim Y.C., Chung H.Y., Son H., Lee Y.S., Studer L., McKay R., and Lee S.H. Dopaminergic neuronal differentiation from rat embryonic neural precursors by Nurr1 overexpression. J. Neurochem. 85 (2003) 1443-1454
12. Lindvall O., and Björklund A. Cell therapy in Parkinson's disease. NeuroRx 1 (2004) 382-393
13. Meyer M., Widmer H.R., Wagner B., Guzman R., Evtouchenko L., Seiler R.W., and Spenger C. Comparison of mesencephalic free-floating tissue culture grafts and cell suspension grafts in the 6-hydroxydopamine-lesioned rat. Exp. Brain Res. 119 (1998) 345-355
14. Meyer M., Johansen J., Gramsbergen J.B., Johansen T.E., and Zimmer J. Improved survival of embryonic porcine dopaminergic neurons in coculture with a conditionally immortalized GDNF-producing hippocampal cell line. Exp. Neurol. 164 (2000) 82-93
15. Ostenfeld T., and Svendsen C.N. Recent advances in stem cell neurobiology. Adv. Tech. Stand. Neurosurg. 28 (2003) 3-89
16. Reuss B., and Unsicker K. Survival and differentiation of dopaminergic mesencephalic neurons are promoted by dopamine-mediated induction of FGF-2 in striatal astroglial cells. Mol. Cell. Neurosci. 16 (2000) 781-792
17. Reuss B., and von Bohlen und Halbach O. Fibroblast growth factors and their receptors in the central nervous system. Cell Tissue Res. 313 (2003) 139-157
18. Reynolds B.A., and Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255 (1992) 1707-1710
19. Roybon L., Christophersen N.S., Brundin P., and Li J.Y. Stem cell therapy for Parkinson's disease: where do we stand?. Cell Tissue Res. 318 1 (2004) 261-273
20. Sayles M., Jain M., and Barker R.A. The cellular repair of the brain in Parkinson's disease - past, present and future. Transpl. Immunol. 12 (2004) 321-342
21. Snyder B.J., and Olanow C.W. Stem cell treatment for Parkinson's disease: an update for 2005. Curr. Opin. Neurol. 18 (2005) 376-385
22. Studer L., Tabar V., and McKay R.D.G. Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats. Nat. Neurosci. 1 (1998) 290-295
23. Timmer M., Muller-Ostermeyer F., Kloth V., Winkler C., Grothe C., and Nikkhah G. Enhanced survival, reinnervation, and functional recovery of intrastriatal dopamine grafts co-transplanted with Schwann cells overexpressing high molecular weight FGF-2 isoforms. Exp. Neurol. 187 (2004) 118-136
24. Timmer M., Grosskreutz J., Schlesinger F., Krampfl K., Wesemann M., Just L., Bufler J., and Grothe C. Dopaminergic properties and function after grafting of attached neural precursor cultures. Neurobiol. Dis. 21 (2006) 587-606
25. Tornqvist N., Bjorklund L., Almqvist P., Wahlberg L., and Stromberg I. Implantation of bioactive growth factor-secreting rods enhances fetal dopaminergic graft survival, outgrowth density, and functional recovery in a rat model of Parkinson's disease. Exp. Neurol. 164 (2000) 130-138
26. West M.J., Ostergaard K., Andreassen O.A., and Finsen B. Estimation of the totalnumber of somatostatin neurons in the striatum: an in situ hybridization study using the optical fractionator method. J. Comp. Neurol. 370 (1996) 11-22
27. Winkler C., Kirik D., and Bjorklund A. Cell transplantation in Parkinson's disease: how can we make it work?. Trends Neurosci. 28 (2005) 86-92
28. Yan J., Studer L., and McKay R.D.G. Ascorbic acid increases the yield of dopaminergic neurons derived from basic fibroblast growth factor expanded mesencephalic precursors. J. Neurochem. 76 (2001) 307-311